Arantes-Oliveira, NunoMancuso, Francesco2025-02-072025-02-072024-07-222024-05-17http://hdl.handle.net/10362/178590The current challenges in the healthcare sector demand innovative solutions. Point-of-care devices are emerging as simplified, efficient, and patient-centric alternatives, often using biosensor technology. SENSO, a miniaturised biosensor, measures inflammation in Polymyalgia Rheumatica (PMR) patients by detecting the H2O2 concentration in a blood drop. Its integration into disease monitoring protocols, both on-site and remotely, promises to enhance patient quality of life while offering an efficient and reliable solution to healthcare professionals. The SENSO company will use PMR monitoring as a proof-of-concept, starting with the Iberian market, while assessing the biosensor’s potential for broader applications in the future.engBiosensorHydrogen peroxideInflammationPolymyalgia rheumaticaDisease biomarkersHealth monitoringPoint-of-careHome careScientific innovationScience-based entrepreneurshipMarket segmentationCustomer preferencesSales strategymaster thesis203725255